Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Rare Dual Genotype IDH-Mutant Glioma: Two Cases of True “Oligoastrocytoma”

              Author:Sutherland, Isabella   DeWitt, John   Thomas, Alissa   

              Session Name:P9: Neuro-oncology: Cases in Neuro-oncology  

              Topic:Neuro-oncology  

              Program Number:P9.002  

              Author Institution:University of Vermont Larner College of Medicine, Burlington, VT  University of Vermont Medical Center, Burlington, VT  

              Neurosarcoidosis Induced by TNF-alpha Inhibitor in a Patient with Ankylosing Spondylitis

              Author:Pak, Daod   Askari, Elham   Treidler, Simona   

              Session Name:P9: Autoimmune Neurology: Neurosarcoidosis / Vasculitis / Neuro-rheumatology  

              Topic:Autoimmune Neurology  

              Program Number:P9.002  

              Author Institution:Stony Brook Medicine, Dept of Neurology, Stony Brook, NY  

              The Mechanism of Disease of Tri-Nucleotide Repeat Expansion Diseases

              Author:De Groen, Piet   

              Session Name:P9: Movement Disorders: Ataxias 2  

              Topic:Movement Disorders  

              Program Number:P9.002  

              Author Institution:University of minnesota, Minneapolis, MN  

              SEIzure InterVAL (SEIVAL) Between Seizure Clusters and Quality of Life Across Time From a Phase 3 Safety Study of Diazepam Nasal Spray for Seizure Clusters

              Author:Misra, Sunita   Sperling, Michael   Rao, Vikram   Peters, Jurriaan   Carrazana, Enrique   Rabinowicz, Adrian   

              Session Name:P9: Epilepsy/Clinical Neurophysiology (EEG): Seizure Cluster and Status Epilepticus  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P9.002  

              Author Institution:Neurelis, Inc., San Diego, CA, San Diego, CA  Thomas Jefferson University, Philadelphia, PA, Philadelphia, PA  University of California, San Francisco, San Francisco, CA, San Francisco, CA  Boston Children’s Hospital, Boston, MA, Boston, MA  Neurelis, Inc., San Diego, CA and John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, Honolulu, HI  

              A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine

              Author:Croop, Robert   Madonia, Jennifer   Hould, Jennifer   Mosher, Linda   Lovegren, Meghan   Lipton, Richard   

              Session Name:P9: Headache: The Gepant Pipeline  

              Topic:Headache  

              Program Number:P9.002  

              Author Institution:Biohaven Pharmaceuticals, Wynnewood, PA  Biohaven Pharmaceuticals, New Haven, CT  Biohaven Pharmaceuticals, Wallingford, CT  Albert Einstein College of Medicine, Bronx, NY